TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019

A Randomized, Double-blinded, Placebo-controlled Trial of Sitagliptin for Reducing Inflammation and Immune Activation in Treated and Suppressed Human Immunodeficiency Virus Infection.

Michael P Dubé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.